Clinical Development Program Lead
Eligo Bioscience mission is to develop treatments and cures for serious diseases in immuno-inflammation, oncology and infectious diseases.
Backed by top-tier investors from Silicon Valley and Europe, Eligo is an industry-leading biotechnology company, co-founded by scientists and professors from MIT and the Rockefeller University – now operating in Paris, France. We are progressing next-generation precision medicines through in vivo gene editing of the microbiome.
Our pioneering work in the field of synthetic biology has enabled Eligo to be elected as one of the 30 Most Innovative Companies by the World Economic Forum, to receive multiple prestigious international awards. We have also been featured in international media and scientific journals such as Nature Biotechnology, Science, The Economist, The BBC and The New York Times.
Eligonauts are driven, passionate, and motivated to impact the lives of patients by applying cutting-edge science to solve real unmet needs. We are at a very exciting point in time of the Eligo journey as we are embarking on the transition from a start-up deeply rooted in innovation to a clinical stage biotech with the objective to bring our lead program to the clinic within the next two years. We are therefore building a development team, in which the clinical development program lead will play a central role.
Eligo Bioscience has attracted highly-diverse top talent from all over the world, who are driven, passionate, and motivated to impact the lives of patients by applying cutting-edge science to save lives and treat chronic disease. Eligo embraces diversity, equal opportunity and inclusion and is committed to building diverse teams.
At Eligo Bioscience, we are passionate about developing new drugs to address unmet medical needs! We are looking for a high-performing and enthusiastic Clinical Development Program Lead to lead our most advanced program, EB005 in moderate-to-severe acne into the clinic and prepare the entry into clinical development of our other programs. We believe that our lead asset EB005 has the potential to drastically reduce the disease burden, and as a Clinical Development Program Lead you will play a central role in bringing this therapeutic opportunity to patients.
The Clinical Development Program Lead provides strategic clinical guidance and leads the development of the EB005 program from preclinical stage to clinical stage, in alignment with company strategy and in accordance with regulatory requirements.